CHO批量培养中单克隆抗体生产动力学:探索细胞外和细胞内动力学。

IF 4.8 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-05-21 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1546105
Alejandro Avilan Garzon, Bruno Ebel, Cédric Paris, Samuel Schneider, David Pfister, Eric Olmos
{"title":"CHO批量培养中单克隆抗体生产动力学:探索细胞外和细胞内动力学。","authors":"Alejandro Avilan Garzon, Bruno Ebel, Cédric Paris, Samuel Schneider, David Pfister, Eric Olmos","doi":"10.3389/fbioe.2025.1546105","DOIUrl":null,"url":null,"abstract":"<p><p>Monoclonal antibodies (mAbs) are complex therapeutic proteins commonly produced by Chinese Hamster Ovary cell culture. Cells are cultivated using a chemically defined medium containing essential nutrients like glucose, amino acids, vitamins, etc., that cells use to grow and produce the target protein among other by-products. Various studies have focused on both extracellular and intracellular culture dynamics, measuring the concentration of various metabolites in the culture medium and inside the cell, but in the vast majority of cases these studies have excluded the intracellular concentration profile of the antibody. To better understand the complexity of the culture process, and the intracellular and extracellular dynamics of the antibody production, the present study focuses on both the extracellular and intracellular biochemical dynamics. A quenching and a lysis protocol were used to obtain the intracellular and the extracellular concentration profiles for the main substrates, metabolites, and mAb during a standard batch culture. The results revealed that three amino acids (glutamine, asparagine, and cystine) were limiting substrates as they were completely depleted almost simultaneously from the culture medium. Intracellular accumulation of different metabolites during the culture process was demonstrated, as well as a 2-day delay between the onset of the intracellular mAb production and its secretion to the culture medium. Finally, a comparison of mass transfer rates across the cell membrane, intracellular production/consumption rates, and accumulation of metabolites in the cell interior revealed that although the intracellular concentrations of the different metabolites changed during the culture process, the dynamics of these variations were much slower than the other two phenomena.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1546105"},"PeriodicalIF":4.8000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134900/pdf/","citationCount":"0","resultStr":"{\"title\":\"mAb production kinetics in CHO batch culture: exploring extracellular and intracellular dynamics.\",\"authors\":\"Alejandro Avilan Garzon, Bruno Ebel, Cédric Paris, Samuel Schneider, David Pfister, Eric Olmos\",\"doi\":\"10.3389/fbioe.2025.1546105\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Monoclonal antibodies (mAbs) are complex therapeutic proteins commonly produced by Chinese Hamster Ovary cell culture. Cells are cultivated using a chemically defined medium containing essential nutrients like glucose, amino acids, vitamins, etc., that cells use to grow and produce the target protein among other by-products. Various studies have focused on both extracellular and intracellular culture dynamics, measuring the concentration of various metabolites in the culture medium and inside the cell, but in the vast majority of cases these studies have excluded the intracellular concentration profile of the antibody. To better understand the complexity of the culture process, and the intracellular and extracellular dynamics of the antibody production, the present study focuses on both the extracellular and intracellular biochemical dynamics. A quenching and a lysis protocol were used to obtain the intracellular and the extracellular concentration profiles for the main substrates, metabolites, and mAb during a standard batch culture. The results revealed that three amino acids (glutamine, asparagine, and cystine) were limiting substrates as they were completely depleted almost simultaneously from the culture medium. Intracellular accumulation of different metabolites during the culture process was demonstrated, as well as a 2-day delay between the onset of the intracellular mAb production and its secretion to the culture medium. Finally, a comparison of mass transfer rates across the cell membrane, intracellular production/consumption rates, and accumulation of metabolites in the cell interior revealed that although the intracellular concentrations of the different metabolites changed during the culture process, the dynamics of these variations were much slower than the other two phenomena.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1546105\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2025-05-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134900/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1546105\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1546105","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

单克隆抗体(mAbs)是中国仓鼠卵巢细胞培养中常见的复杂治疗蛋白。细胞是用含有葡萄糖、氨基酸、维生素等必需营养物质的化学培养基培养的,细胞利用这些营养物质生长并产生目标蛋白质和其他副产品。各种研究都侧重于细胞外和细胞内的培养动力学,测量培养基和细胞内各种代谢物的浓度,但在绝大多数情况下,这些研究都排除了抗体的细胞内浓度谱。为了更好地理解培养过程的复杂性,以及抗体产生的细胞内和细胞外动力学,本研究将重点放在细胞外和细胞内的生化动力学上。在标准批量培养过程中,采用淬火和裂解方法获得主要底物、代谢物和单抗的细胞内和细胞外浓度谱。结果显示,三种氨基酸(谷氨酰胺、天冬酰胺和胱氨酸)是限制性底物,因为它们几乎同时从培养基中完全耗尽。在培养过程中,细胞内积累了不同的代谢物,并且在细胞内产生单抗和向培养基分泌单抗之间有2天的延迟。最后,通过细胞膜传质速率、细胞内生产/消耗速率和代谢物在细胞内部积累的比较表明,尽管在培养过程中不同代谢物的细胞内浓度发生了变化,但这些变化的动态要比其他两种现象慢得多。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
mAb production kinetics in CHO batch culture: exploring extracellular and intracellular dynamics.

Monoclonal antibodies (mAbs) are complex therapeutic proteins commonly produced by Chinese Hamster Ovary cell culture. Cells are cultivated using a chemically defined medium containing essential nutrients like glucose, amino acids, vitamins, etc., that cells use to grow and produce the target protein among other by-products. Various studies have focused on both extracellular and intracellular culture dynamics, measuring the concentration of various metabolites in the culture medium and inside the cell, but in the vast majority of cases these studies have excluded the intracellular concentration profile of the antibody. To better understand the complexity of the culture process, and the intracellular and extracellular dynamics of the antibody production, the present study focuses on both the extracellular and intracellular biochemical dynamics. A quenching and a lysis protocol were used to obtain the intracellular and the extracellular concentration profiles for the main substrates, metabolites, and mAb during a standard batch culture. The results revealed that three amino acids (glutamine, asparagine, and cystine) were limiting substrates as they were completely depleted almost simultaneously from the culture medium. Intracellular accumulation of different metabolites during the culture process was demonstrated, as well as a 2-day delay between the onset of the intracellular mAb production and its secretion to the culture medium. Finally, a comparison of mass transfer rates across the cell membrane, intracellular production/consumption rates, and accumulation of metabolites in the cell interior revealed that although the intracellular concentrations of the different metabolites changed during the culture process, the dynamics of these variations were much slower than the other two phenomena.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信